Get notified when XENE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsXenon Pharmaceuticals files routine annual meeting notice with Canadian regulators
Filed March 13, 2026 · Period ending March 13, 2026 · ~1 min read
Key Changes
-
low
Company announced details for its 2026 annual shareholder meeting through a Canadian SEDAR+ filing, including meeting date and record date information.
Item 8.01 verify on EDGAR → -
low
This 8-K is a procedural cross-reference to a Canadian regulatory filing with no material business disclosures or operational updates.
8-K: SEDAR+ Filing verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.
Partner
Trade XENE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify